Triampyzine
A diuretic medication
Triampyzine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Triampyzine is a pharmaceutical drug that belongs to the class of diuretics, specifically a combination of a thiazide diuretic and a potassium-sparing diuretic. It is used primarily in the management of hypertension and edema associated with congestive heart failure, liver cirrhosis, and renal disorders.
Pharmacology[edit | edit source]
Triampyzine combines the effects of two types of diuretics: a thiazide diuretic and a potassium-sparing diuretic. The thiazide component works by inhibiting sodium reabsorption in the distal convoluted tubules of the nephron, leading to increased excretion of sodium and water. This action helps reduce blood volume and, consequently, blood pressure.
The potassium-sparing component of Triampyzine helps to prevent the loss of potassium, a common side effect of thiazide diuretics. By conserving potassium, Triampyzine reduces the risk of hypokalemia, which can lead to muscle weakness, cramps, and cardiac arrhythmias.
Medical Uses[edit | edit source]
Triampyzine is indicated for the treatment of:
- Hypertension: It helps lower high blood pressure, reducing the risk of stroke and myocardial infarction.
- Edema: It is used to manage fluid retention in conditions such as congestive heart failure, liver cirrhosis, and nephrotic syndrome.
Side Effects[edit | edit source]
Common side effects of Triampyzine include:
Serious side effects may include:
Contraindications[edit | edit source]
Triampyzine is contraindicated in patients with:
- Anuria
- Severe renal impairment
- Hyperkalemia
- Known hypersensitivity to thiazides or potassium-sparing diuretics
Mechanism of Action[edit | edit source]
The thiazide component of Triampyzine inhibits the sodium-chloride symporter in the distal convoluted tubule, leading to increased excretion of sodium and chloride ions. The potassium-sparing component acts on the distal nephron to inhibit sodium reabsorption and potassium excretion, thus conserving potassium.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD